Giants of Cancer CareĀ® Program Inductees


Steven A. Rosenberg, MD, PhD

National Cancer Institute

  • Pioneered the use of adoptive immunotherapy.
  • Chief of Surgery at the National Cancer Institute.
  • Credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer.
  • Has shown that expanding immune cells (known as tumor infiltrating lymphocytes) in the lab can be used to treat patients with melanoma.
Back to 2013 Inductees